Quantcast

Latest Insulin Stories

2014-02-18 08:32:39

To widen market potential, pharma companies must roll out long-lasting therapies that delay or prevent disease progression BUENOS AIRES, Argentina, Feb. 18, 2014 /PRNewswire/ -- The Latin American diabetes therapeutics market will experience major changes within the next three years due to the launch of innovative drugs that include three long-acting insulins and four non-insulin treatments. Nevertheless, pharmaceutical companies should continue their research to develop treatments that can...

2014-02-14 11:09:28

A protein that has been known until recently as part of a complex communications network within the cell also plays a direct role in regulating sugar metabolism, according to a new study published on-line in the journal Science Signaling (February 18, 2014). Cell growth and metabolism are tightly controlled processes in our cells. When these functions are disturbed, diseases such as cancer and diabetes occur. Mohamed Soliman, a PhD candidate at the Lunenfeld Tanenbaum Research Institute at...

2014-02-12 23:25:21

ManageBGL.com, a web site for people with diabetes, predicted a diabetic child’s critically low blood sugar, potentially saving her life. ManageBGL is now crowdfunding for native mobile apps to help 382 million diabetics worldwide. Melbourne, Australia (PRWEB) February 12, 2014 ManageBGL prevented a tragedy when it predicted an eight-year old girl with Type 1 (Insulin-dependent) diabetes would have a dangerously low blood sugar (hypoglycaemia or ‘hypo’) during a school swimming...

2014-02-12 12:31:50

In an unprecedented, challenging environment for reimbursement and choice for people with diabetes, ACCU-CHEK remains highest ranked brand INDIANAPOLIS, Feb. 12, 2014 /PRNewswire/ -- J.D. Power has announced that Roche Diabetes Care's ACCU-CHEK products rank "Highest in Customer Satisfaction with Blood Glucose Meters" among adults living with diabetes in the U.S. for the second year in a row according to the 2013 Blood Glucose Meter Satisfaction Study(SM). In a study comprised of...

2014-02-12 08:30:06

More than half a million dollars donated to help children with diabetes attend camp since 2008 INDIANAPOLIS and ALEXANDRIA, Va., Feb. 12, 2014 /PRNewswire/ -- News Highlights: -- #Lilly #Diabetes supports @AmDiabetesAssn #camps by donating $91,000 to send 91 children with diabetes to camp in 2014 -- #Lilly #Diabetes donates $91,000 to the @AmDiabetesAssn 2014 #camp program -- #Lilly #Diabetes supports scholarship program for children with #T1 #diabetes;...

2014-02-12 08:28:24

Clinical program focused on reversing type 1 diabetes symptoms in patients diagnosed within six months of trial initiation EDGEWATER, N.J. and SAN DIEGO, Feb. 12, 2014 /PRNewswire/ -- DiaVacs, Inc., a clinical stage biotechnology company focused on developing cell-based therapy for treatment of type 1 diabetes, and Profil(® )Institute for Clinical Research, Inc., an early phase clinical research organization focused on diabetes and obesity, announced today a strategic collaboration...

2014-02-11 12:27:38

The Biggest Loser RunWalk and The Biggest Loser Resorts Will Sponsor 5K Race at Annual Event Which Raises Funds for Diabetes Research Institute MIAMI, Feb. 11, 2014 /PRNewswire-USNewswire/ -- The Diabetes Research Institute Foundation has once again teamed up with Walgreens, the nation's largest drugstore chain, for the DRI Walk for Diabetes & Family Fun Day. This marquee event along with The Biggest Loser RunWalk 5K will be held the morning of Saturday, March 8, 2014 at Sun Life...

2014-02-11 08:32:23

LA CHAUX-DE-FONDS, Switzerland, February 11, 2014 /PRNewswire/ -- Kareus Therapeutics SA ("Kareus") announced today that US FDA has approved its Investigational New Drug (IND) KU-5039 to initiate Phase I clinical trial. KU 5039 is being developed for the treatment of insulin resistance and diabetes. KU-5039 is an orally active, New Chemical Entity (NCE), discovered and developed by Kareus. KU-5039 is a potent and selective activator of AMP-kinase (AMPK), a key...

2014-02-11 08:30:24

Research advances in novel pathways produce innovative antidiabetic drugs, which will pave the way for successful market penetration LONDON, Feb. 11, 2014 /PRNewswire/ -- Type 2 diabetes is one of the most significant global health concerns of modern times. According to the International Diabetes Federation, more than 55 million people have been diagnosed with diabetes in Europe in 2012, and this number is expected to rise to 64 million by 2030. A recent research by Frost &...

2014-02-10 12:25:17

JERUSALEM, Feb. 10, 2014 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that it has submitted a protocol to the U.S. Food and Drug Administration (FDA) to initiate a Phase 2a trial of its orally ingestible insulin capsule, ORMD 0801, for type 1 diabetes. The protocol was submitted under Oramed's existing IND for ORMD-0801 to include both...


Latest Insulin Reference Libraries

Pancreas
2013-01-02 11:22:15

The pancreas is a digestive and an endocrine organ with both endocrine and exocrine functions. It is about six inches long located in the upper portion of the abdominal cavity. The head of the pancreas lies within the indentation of the duodenum and is connected to it by the pancreatic duct. The uncinate process extends from the head and the neck connects to the body of the pancreas, which lies directly behind the stomach. The tail of the pancreas extends to the left side of the body and is...

0_0d961f30bdfa64859d9b869b063ddcd2
2010-12-03 18:12:26

Insulin, a hormone, is used to regulate carbohydrate and fat metabolism in the body. Insulin causes cells to take up glucose from the blood and store it as glycogen in the liver and muscle. This hormone stops the body from using fat as an energy source by inhibiting the release of glucagons. Without insulin the body fails to take glucose into the bodies cells and in turns uses fat as an energy source. It also has several other anabolic effects throughout the body. Diabetes mellitus results...

More Articles (2 articles) »
Word of the Day
grass-comber
  • A landsman who is making his first voyage at sea; a novice who enters naval service from rural life.
According to the OED, a grass-comber is also 'a sailor's term for one who has been a farm-labourer.'